Platelet activation and lipid peroxidation in patients with acute ischemic stroke

Stroke

Volumn 28, Issue 8, 1997, Pages 1557-1563

  Van Kooten, Fop ^a   Ciabattoni, Giovanni ^b   Patrono, Carlo ^c   Dippel, Diederik W J ^a   Koudstaal, Peter J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cerebral ischemia; Lipid peroxidation; Platelet activation; Thromboxanes

Indexed keywords

ARACHIDONIC ACID; FREE RADICAL; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE; THROMBOXANE A2;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; THROMBOCYTE ACTIVATION;

EID: 0030791070     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.8.1557     Document Type: Article

References (15)

1. Koudstaal PJ, Ciabattoni G, van Gijn J, Nieuwenhuis K, de Groot PG, Sixma JJ, Patrono C. Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke. 1993;24:219-223.
2. van Kooten F, Ciabattoni G, Patrono C, Schmitz PIM, van Gijn J, Koudstaal PJ. Evidence for episodic platelet activation in acute ischemic stroke. Stroke. 1994;25:278-281.
3. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A. 1990;87:9383-9387.
4. 2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A. 1992;89:10721-10725.
5. 2α, is formed in vivo. Biochim Biophys Acta. 1994;1210:244-248.
6. Morrow JD, Minton TA, Mukudan CR, Campbell MD, Zackert WE, Daniel VC, Badr KF, Blair IA, Roberts LJ II. Free radical-induced generation of isoprostanes in vivo: evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem. 1994;269:4317-4326.
7. 2α, in the rat: evidence for interaction with thromboxane A, receptors. J Clin Invest. 1992;90:136-141.
8. 2 alpha, in rabbit lung in situ. Am J Physiol. 1992;263:H660-H663.
9. Kang KH, Morrow JD, Roberts LJ II, Newman JH, Banerjee M. Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lung. J Appl Physiol. 1993;74:460-465.
10. 2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins. 1992;44:155-163.
11. 2 receptors in human platelets. J Pharmacol Exp Ther. 1994;270:1192-1196.
12. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
13. 2-isoprostanes) in the hepatorenal syndrome. J Lipid Mediat. 1993;6:417-420.
14. 2α levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 1995;368:225-229.
15. Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 1996;94:19-25.